---

$2.87

+0.0050 ( +0.18% ) 1.7M

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-08-25	Buy	25000.00	Gregory Dean A.
2025-01-02	Buy	1725.00	Gregory Dean A.
2024-08-07	Sale	-21605.00	Benjamin Richard J
2024-07-02	Sale	-60000.00	Gregory Dean A.